Clinical Trial and Sponsored Research Agreements (Tables)
|3 Months Ended|
Mar. 31, 2022
|Sponsored Research and Clinical Trial Agreements [Member]|
|Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]|
|Schedule of Clinical Trial and Sponsored Research Agreements||
For the three months ended March 31, 2022 and 2021, the Company recorded the following expense in research and development for sponsored research and clinical trial agreements in the Unaudited Condensed Statements of Operations pursuant to the terms of this agreement:
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
No definition available.
Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef